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Scales from patients with 110npustular psoriasis were in-
vestigated for the presence of peptides capable of activating 
functional activities in human polymorphonuclear leuko-
cytes (PMNL) . Two compounds with similar molecular 
weight (12,500 and 15,000) were isolated which markedly 
stimulated PMNL functional activities including chemo-
taxis, generation of superoxide radical anion (0 2), and lib-
era tion of f3-glu curonidase as a marker enzyme. As revealed 
by ion-exchange and subsequent radioimmunoassay fol-
lowed by chromatofocusing, one peptide proved to be the 
desarginated form of the complement split product C5adcs 
O ne of the intriguing aspects of the infl ammatory tiss ue reaction in psoriasis consists in polymor-phonuclea r leukocytes (PM NL) mig ratin g trans-epidermally toward the keratogenous zone [1]. Whereas these alterations histolog icall y are clearly 
defined , the biochemical mediators participatin g in these events 
are not well known. In recent years lipid-like [2,3] as w ell as 
peptide-like [4,5] compounds with the capacity to stimulate PMNL 
were seen in psoriatic epidermis including sca les. 
Concentrating on peptide-like mediators, Tagami et al [6] found 
a chemotactic factor which was called "psoriatic leukotactic fac-
tor" (PLF). This factor was shown to possess some of the char-
acteristics of the complement split product C5a [6]. 
Because in psoriasis as well as in other infl ammatory skin dis-
eases identification of the principal mediators with neutrophil-
activating capacity m ay help to further understand the disease 
pathomechanism. we have investiga ted psoriatic scales for the 
presence ofPMNL-activating peptides. We were able to identify 
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Abbreviations: 
ANAP: anionic neutrophil-acti va ting peptide 
BSA: bovine serum albumin 
C5a: complement split product 
ETAF: epidermal cell-derived thymocyte-activating factor 
FMLP: formylated tripeptide 
11-1: interleukin 1 
IP: isoelectric point 
MOC: monocyte-derived chemotactic factor 
0 2" : superoxide radical anion 
PAF: platelet-activating fac tor (C I 8) 
PBS: phosphate-buffered saline. 0.04 M sodiulll phosphate, 0.254 
M NaCl. pH 7.3 
PMNL: polymorphonuclear leukocytes 
argo No C5a was detectable. 
As a second psoriatic scale chemotaxin we isolated an 
anionic neutrophil-activating peptide (ANAP) which shows 
a single isoelectric point at pH 6.8. This peptide shares 
som e of the characteristi cs of epidermal cell-derived th y-
mocyte-activa ting factor and interleukin 1 and , as shown 
by deactivation experiments, it cross-reacts with a mono-
cyte-derived cytokine. The 2 newly described neutrophil-
activating peptides (C5adcs arg and ANAP) may play an 
important role in the psoriatic tissue reaction. ] Invest Der-
matoI87:53-58, 1986 
C5adcs orB as well as an anioni c peptide as potent activators of 
neutrophil funct ions. 
MATERIALS AND METHODS 
C rude sca les were collected in a tota l of9 patients w ith untreated 
pso riasis vulga ris. Diagnosis of psorias is was well es tablished by 
clinical criteria and all pati ents were hospitalized for subsequent 
trea tment . Between 2-10 g crude scales were collected from each 
patient. 
Preparation of Scale Extracts The scales (2-10 g) were sus-
pended in 200 III 1 phosphate-buffered saline (PBS), pH 7.4, and 
homogenized using an ultraturrax for 10 min in an ice bath. 
The homogenate was centrifuged (1000 g for 30 min) , th e su-
pernatant was fi ltered through a 0.45-,um filter and therea fter the 
filtrate was concentrated 50-fold usi:1g Amicon YM 5 filters 
(Amicon Corp .) and stored below -70°C for chro matogra ph y. 
Preparation of PMNL Polymorphonuclear leukocytes from 
hea lthy don ors were isolated as previousl y descr ibed [7] using a 
slight modifica tion of the method of H enson [8]. U sing this tech-
niqu e final cell preparations contained mo re than 90% nelltrophils 
with a viability of grea ter than 97% as assessed by try pan blue 
exclusion. 
Chemotactic and Random Migration Chemotactic and ran-
dom migra tion of PMNL were assayed using a modification of 
the "endogenous component chemotactic assay (ECCA) " m ethod 
described by C rea mer et al [9] using /3-glucuronidase as marker 
enzy me. 
Production of Superoxide Anions (Oi ) Superoxide anion-
production was measured using a slight modification of the method 
described by English et al [10]. 
In order to ascerta in proper controls, sllperoxide disl11utase 
(bovine blood, Sigma. Munich, 1 m g/ml PBS) was added to 
control tubes in each experiment prior to th e addition of cells to 
stop the redu ction of cytochrome C by O 2 [11]. 
Redu ced cytochrome C was assayed in supernatants by mea-
suring the extin ctions at 550 and 540 nm (H itachi 150-20 spec-
0022-202X/86/S03.50 Copyright © 1986 by The Society for Investigative permatology, Inc. 
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trophotometer) vs blanks containing superoxide dismutase at the 
start of the reactions. 0 2" concentrations were calculated using 
an extinction coefficient of 15.5/mM x cm (ferrocytochrome C 
minus ferricytochrome C) [10]. 
When 0 2" production elicited by G-75 fractions was measured, 
8 x 106 ne'utrophils per assay (total volume: 1 ml) were used after 
preincubation (10 min, 37°C) with cytochalasin B (5 fLg/ml) . 
Enzyme Release 
f3-Chlcuronidase Release: The marker enzyme of PMNL azuro-
philic granules, f3-glucuronidase, was measured as described pre-
viously [12]. A 100% control was obtained by addition of 100 fLI 
0.2% Triton X-I 00 instead of the stimulus. Release of f3-glucu-
ronidase was expressed in percent of the Triton X-I00-control 
(= 100%). 
Myeloperoxidase Release: The second marker enzyme of P MNL 
azurophilic granules, myeloperoxidase, was measured as de-
scribed by Pember and Kinkade [13]. In this assay o-phenylen-
diamin-dihydrochloride instead of guajacol was used as substrate. 
A 100% control was obtained by addition of 100 fl.l 0.2% hexa-
decyl-trimethylammonium-bromide (Sigma) in water instead of 
the stimulus. 
LactoJerrin Release: Lactoferrin-a marker protein ofPMNL sec-
ondary granu les-was measured by enzyme-linked immunosor-
bent assay (ELISA) using a modification of the method recently 
described by Vilja et al [14]. Briefly, in this system affinity-pu-
rified antihuman lactoferrin-igG antibodies (Miles GmbH, Frank-
furt , F.R. G.) were used , which were coupled with biotin-N-
succinimide. Biotin antibodies bound to lactoferr in were deter-
mined by avidin-peroxidase. T his assay allowed measurement of 
low amounts (50 pg) of lactoferrin released from activated neu-
trophils. A 100% control was obtained by additions of PBS in-
stead of the stimulus and 3-fold freezing and thawing. Release of 
lactoferrin was expressed in percent of the frozen/thawed (3 x ) 
control. 
Chemotactic Factors Purified C5a was prepared according to 
a combination of the methods described by Fernandez and Hugli 
[15] and Beebe et al [16] as described earlier [17] . C5adcs " S was 
prepared in a similar manner, however in the absence of the serum 
carboxypeptidase N-inhibitor E-am.ino caproic acid. Both com-
pounds showed different elution pattern, when chromatofocused 
at polybuffer exchanger PBE 9/11 with Polybuffer 8-10.5 for 
elution . Column fractions were assayed for O 2 stimulating ca-
pacity with neutrophils . 
A chemotactic factor derived from adherent monocytes (MOC) 
was obtained according to the method described for isolation of 
interleukin 1 (11-1) in the absence of serum [18]. Briefly adherent 
mononuclear leukocytes were stimulated with Escherichia coli lipo-
polysaccharide (10 fLg / ml) (Sigma) as well as silica (10 fLg/ml) in 
medium RPMI for 24 h at 37°C. . 
Supernatants were concentrated using Amicon YM 5-ultrafil-
ters and chromatographed on Sephadex G-75. Fractions, which 
stimulated migration of test neutrophils, were collected (M, 
- 12,500) , concentrated with YM 5-filters, and pooled below 
-70°C. This adherent monocyte-derived chemotaxin (MOC) 
stimulated migration, release of f3-glucuronidase, peroxidase, and 
lactoferrin as well as reduction of cytochrome C of human neu-
trophils. 
Sephadex G-75 Chromatography Concentrated scale ex-
tracts were chromatographed on Sephadex G-75 gel (column: 
2.5 x 65 cm, Pharmacia, Uppsala, Sweden) with PBS (pH 7.2) 
at 4°C and separated into 5-mJ fractions . After adding CaCb and. 
MgCIz (final concentrations of 1.3 and 1.0 mM, respectively), 
fractions were tested for migration stimulating activity, O 2-
generating activity, as well as f3-glucuronidase- or myeloperox-
idase-liberating activity with test neutrophils. As molecular mark-
ers, blue dextran, bovine serum albumin (BSA), complement 
fragment C5a, cytochrome C, as well as vitamin BI2 were used 
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and the eluted compounds were detected spectrophotometrically 
at 280 nm. The position of marker C5a was estimated by peak 
neutrophil-O 2 production. 
When necessary, fractions were concentrated by use of YM-5 
membranes . 
Chromatofocusing Fractions of G-75 chromatography acti-
vating PMNL functions at the M, range 10,000-20,000 were con-
centrated and diafiltered w ith the appropriate starting buffer. 
Chromatofocusing was done in 2 pH-intervals: for alkaline 
chromatofocusing, a column of polybuffer exchanger (PBE 118) 
was equilibrated with 0.025 M triethylamine-HCI and elution 
performed using Phannalyte pH 8-10.5 (Pharmacia, Uppsala, 
Sweden) obtaining a pH gradient from pH 10.5-pH 8. For acidic 
chromatofocusing, a column of polybuffer exchanger (PBE 94) 
was equilibrated w ith 0.025 M imidazole-HCl and elution per-
formed using polybuffer 74-HCI obtaining a pH-gradient within 
pH 7 and 4. 
Fractions were concentrated using centricon 10-microconcen-
trators (Amicon GmbH, Witten, F.R.G.) and eq uilibrated with 
PBS. T hereafter they were tested for biologic activity (stimulation 
of migration, 0 2" production or enzyme release) using test neu-
trophils. 
Ion-Exchange Chromatography G-75-chromatography frac-
tions which activated PMNL functions (M, range 10,000-20,000) 
were equilibrated with 0.005 M sodium phosphate, 0.002 M EDTA, 
pH 7.8, and then applied to a small column (2 x 0.5 cm) of CM-
50-Sephadex, which was equilibrated with the SalTle buffer. The 
column was washed with 10 ml equilibration buffer. Bound sub-
stances eluted with 10 mJ 0.2 M glycine-HCI buffer, containing 
1 M N aCI, pH 2.5, and fractions were immediately neutralized 
using solid Tris. Both pools with the basic as well as acidic com-
ponents were diafiltered against PBS using Amicon YM-5 filters , 
concentrated, and tested for biologic activity as described. 
Deactivation Experiments In some experiments , stimulus-
specific deactivated neutrophils were used as test cells. For this 
purpose neutrophils were preincubated either with C5a or with 
partially purifIed MOC for 20 min at 37°C. T hereafter cyto-
chalasin B was added giving a final concentration of 5 fLg/ml and 
cells were incubated for an additional 5 min. Then fractions were 
added and incubated for 30 min at 37°C. After centrifugation the 
supernatants were tested for f3-glucuronidase activity . 
Controls were performed using C5a, MOC, and formylated 
tripeptide (FMLP) as stimuli. In all cases deactivation was stim-
ulus-specifIc as revealed by the lack of inhibition of enzyme release 
in cells exposed to other stimuli at optimal concentrations. 
Radioimmunoassay (RIA) for C5a and C5ades arg In the col-
umn fractions as well as crude scale extracts C5adcs arg was de-
termined using a commercial RIA kit (Upjohn GmbH, Heppen-
heim, F.R.G.) using the instructions of the manufacturer [19]. 
RESULTS 
Separation of psoriatic scale extracts by G-75 chromatography 
revealed peak biologic activity in fractions which correspond to 
the M, of 10,000-20,000 (Fig 1) . 
Biologic activity was seen with each of the functional param-
eters tested, e. g., stimulated migration, release of f3-glucuroni-
dase, and generation of O 2 . In contrast to enzyme secretion and 
generation of O 2 both of which showed 2 distinct peaks of ac-
tivity (Fig 1), migratory activities were stimulated by a much 
wider range of fractions with one peak only . 
Using PMNL which had been preincubated with C5a and, as 
seen in control experiments (data not shown) were in a deactivated 
state, these C5a-deactivated cells were then stimulated with scale 
fractions separated by G-75 chromatography . Fig 2 shows that 
enzyme release stimulated by near 12 kD fractions was nearly 
unaltered. However, degranulation elici ting activity was de-
creased when fractions corresponding to 15 kD were used as 
stimuli (Fig 2) . 
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Figure 1. Sephadex G-75 chromatography of psoriasis scale extract. 
Neutrophil chemotactic activity (solid circles) as well as ,B-glucuronidase 
liberating acti vity in PMNL (opell circles) were elicited by the column 
fractions. Peak elution of marker substances C5a (15 kO) and cytochrome 
c (12.4 kO) are indicated. 
Fractions corresponding to 10-20 kD were subsequently ex-
amined for the presence of C5a o r C 5adcs acs by radioimmunoas-
say. As shown in Fig 3, C5 split product(s) was present with peak 
activity corresponding to 15 kD (Fig 3). No C5a activity could 
be detected within the 12 kD fractions. In subsequent experiments 
the 10-20 kD fraction s obtained by G-75-chromatography were 
chromatofocused within the pH range of 8-10.5. This sys tem 
enabled us to separate C 5a and C 5adcs " g' the latter eluating at a 
lower pH than C5a. When the chromatofocusing column was 
reequilibrated, biologic ac tivity eluted at th e sa m e position as 
authentic C5dcs acs (Fig 4). This is additional evidence that the 15 
kD frac tions contain desarginated C5a as a principal factor. 
Characterization of the 12 kD Fraction Fractions within the 
10-20 kD range were furth er chara cteri zed by Sephadex C M-50 
ion-exchange chromatography. Preliminary experiments showed 
that the 10-20 kD-pool from G-75 chromatogra phy contained 
chemotaxins which proved to be ca tionic as well as anion.ic. Sub-
sequently fractions o btained by G-75 chromatography were di-
vided into 2 pools (pool I and pool II) according to polarity 
(anionic or cationic peptides, Fig Sa). Pooled fractions of the 10-20 
kD range were then separated by C M-50-Sephadex ion exchange 
and tested for biologic activity (Fig 5b,e). 
Fractions with peak activity at 15 kD showed predo minantl y 
cationic behavior (Fig 5b) whereas the act ivity eluting later cor-
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Figure 2. ,B-Glucuronidase liberating activity by G-75 chroma tography 
fractions identical with those shown in Fig 1 using C5a-deactivated test 
neutrophils. Note loss of enzyme releasing activity in fractions 36-40. 
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Figure 3. CSa radioimmunoassay (opell circles) of G-7S chromatography 
fra ctions showing ,B-glucuronidase releasing activity (so lid circles) . Note 
that fract ions containing highes t amounts of C5a by radioim munoassay 
correspond to fra ctions showing peak release of ,B-glucuronidase. 
responded to acid ic components (Fig 5c). In this way the 2 frac-
tions revealing peak biologic activities were sepa rated, resulting 
in a catio nic com po nent (evidently C5adcs acg) and a newly detected 
anionic factor with a slightly lower M,. 
For further characteriza tion , contaminating C5adcs a,s w as ab-
sorbed using C M -50-Sephadex and the anionic components were 
chro m atofocused in the pH range of 7.4- 4. 
To o ur surprise exa mination of these fractions for biologic 
activity revealed a sing le peak eluting at pH 6.8 (Fig 6) . These 
fra ction s were ab le to elicit migrato ry activity in PMNL (data 
not shown) as well as th e release of m yelo peroxidase (Fig 6). 
It should be mentioned that measurements of biologic activity 
of chro matofocusing fractions may be hampered by low ion con-
tents as well as by different pH of the column fract ions. In order 
to overcom e such di fficulties, large am ounts of partially purified 
extracts (100 times the half maximal chemotaxis stimulatory doses) 
were chromatofocused. Also these frac tions were concentrated as 
well as diafiltered against physio logic buffer. Under these con-
ditio ns no additional activity peaks were seen to be present at 
lower elution pH. 
Further characteristics of this peptide are shown in Table I. As 
can be seen from this table the factor activa tes O 2 production , 
pH 
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Figure 4. Chromatofocusing of partially purified ca tionic neutrophil-
activating activi ty of a 10-20 kO G-75 chromatography pool from pso-
riatic scales . Cationic pep tides of the 10-20 kD pool bound to CM-
Sephadex were el uted with glycine buffer (pH 3) and these peptides were 
sepa rated by alka line chromatofocusing. The chromatofocusing column 
has been calibrated with authentic sa mples of C5a as well as CSadcs " S 
(solid circles). Biologic activi ty of ca tionic psoriatic scale pep tides (opel/ 
circles) is present at the position of C5adc, "g. The pH is shown by crosses. 
56 SCHRODER AN D C HRISTOPH ERS 
.---. Pool I Pool][ 
iii 50 I I .... (\ ,s2 '0 40 * L-....I Cl 30 1/1 i \.'\ III .J! ~ I ~ /e ~ >-N 
c: 
a 
w II I i I 
35 40 45 50 
Fract ion Number 
Pool I b 
'=' re III ;2 
'020 e \ 
~ 
ai pH3 1/1 
III t ~10 
I 
t l\ 
N 
-- .-.-e c: 
w I i I I 
5 10 15 
Pool ][ 
c 
!\ 
e e 
e 
I ~ Ie e-e/e \_ e 
/I I I I 26 2'5 5 10 15 
Figure S. a, Fractions of G-75 chro matography within .the range 10- 20 
kD were divided into pool' (peak near 15 kD) and pool II (peak near 
12.4 kD). b, T he activity p rofile of pool I w hen ch romatographed on 
C M-Sephadex 50. It is nota ble that the m ain activity binds to the ca tion 
exchanger, w hich elu ted at low pH. c, Pool II contains m ainly compounds 
w hich do not bind to the ca tion exchanger. 
release of /3-glucuronidase, as well as myeloperoxidase and lac-
tofer rin in cy tochalasin B-treated neutrophils. In all our PMNL 
assays, tllis anionic neutrophil-activating facto r (ANAP) produced 
typical dose-response curves (data not shown) . When half-max-
imum eliciting doses for PMNL fun ctional parameters w ere com-
pared, chemotaxis was stimulated at much lower concentration 
as compared with 0 "2 production and release of /3-glucuronidase 
(Table I). T he di ffe rences in concentrations (ED so) were approx-
imately 50-fold. 
Deactivation Experiments Cells preincubated with ANAP 
and subsequently exposed to C5a, FMLP, PAF, and ANAP showed 
specific deactivation of enzyme release elicited by ANAP whereas 
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Figure 6. C hromatofocusing o f partially purified anionic neutrophil ac-
ti va ting component of a 10-20 kD G-75 chro matograph y pool from 
psoria tic scales. Anionic peptides of the 10- 20 kD pool w hich did not 
bind to C M-Sephadex were separa ted by acidic chro matofocusing. M ye-
loperoxidase liberating activity (solid circles) of tes t neutrophils and pH 
(opetl circles) are shown. Prior to biologic test these fractions were diaftl-
tered against PBS and concentra ted . 
no impairment of the enzy me-releasing activity was seen after 
stimulation with C5a, FMLP, or PAF (T able II) . This indicates 
that ANAP apparently does not affec t the receptor binding of 
these chemotaxins. 
Finally, pretreatment of PMNL with a M OC [20] and vice 
versa clearly revealed cross deactivation fo r ANAP and M Oe 
w hile full res ponses could be eli cited with other chemotaxins 
(C5a, FMLP, and PAF) (Table II). In addi tion, pre trea tment of 
neutrophils w ith M OC revealed the PMNL nonresponsive to 
ANAP (Fig 7), however not to o ther chemotaxins (T able II). 
These experiments indicate binding of both chemotaxins (MOe 
and ANAP) to the same chemotaxin recepto r on neutrophils. 
DISCUSSIO N 
U sing large am ounts of scales obtained from patients w ith non-
pustular psorias is w e were able to identify 2 compounds with 
similar M, (1 2,500 and 15,000) w hich markedly stimulated neu-
trophil fun ctions. 
By ion-exchange chromatography one of these 2 components 
was fo und to be cationic and one w as anionic. As revealed by 
radioimmunoassay and subsequently by chromatofocusing, the 
cationic pso riatic scale peptide proved to be the desarginated form 
of C5a (C5adcs arg). 
In a chro matographic analysis of psori atic scale extracts using 
Sephadex G-75 profiles Tagami and O fuji [4] were able to identify 
fragments of the fifth complement component. Based on cation 
exchange chro matography of these fractions the authors suspected 
the presence o f the anaphylatoxin C5a in psoriatic scales [6]. 
By assaying the chromatofocusing fractions for biologic activ-
Table I. N eutrophil Activating Properties of ANAP" 
Function 
C hemotactic mig ration 
C hemokinetic m igra tion 
I3-Glucuronidase release 
0 2" productio n 
Lactoferrin release 
46 ± 12 
55 ± 23 
16 ± 7 
"Partiall y purified anionic neutrophil-activating peptide (ANAP) has been used. 
Puri fica tion scheme: (a) G-75-chromatography of a scale extract; (b) C M 50-Seph. 
adex-chromatog raphy from a 10-20 kD G-75 pool. T his preparation did not COnt. in 
significa nt amoun ts of contaminating CS3dc:s u s' 
'Arbitrary dose of AN Al' necessary fo r half-maximum chemotactic stim ulation. 
Resul ts of 3 dose response studies performed in duplicate are shown. I 
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Table II. Cross-Reactivity of PMNL Responses After Preincubation w ith C hemotaxins 
C5a 
(10 - 8 M) 
C5a 28.6 ± 9.4 
10 - 8 
FMLP 97. 1 ± 1. 2 
1 x 10 - 8 M 
PAF 11 0.2 ± 14.3 
3 x 10 - 6 M 
ANAP 100.0 ± 8.7 
40 ECso 
MOC 100.4 ± 9.3 
40 ECso 
Stimulation with 
FMLP PAF 
(1 X 10 - 8 M) (3 X 10 - (' M) 
10.20 ± 9.4 83. 1 ± 16.2 
36.0 ± 11.1 88.0 ± 7.9 
11 7.5 ± 12.4 15.8 ± 4.5 
92.9 ± 7.6 100.0 ± 11 .3 
98.7 ± 5.8 110.6 ± 11.8 
ANAP 
(20 ECso) 
92.0 ± 9.6 
95. 1 ± 5.4 
11 5.4 ± 6.7 
22.2 ± 2.3 
26.9 ± 4.2 
MOC 
(20 ECso) 
89.0 ± 12.3 
93.0 ± 10.0 
135.9 ± 10.0 
26.9 ± 4.8 
23.5 ± 3.7 
Enzy m e rel ease (f3-g lu curo nidasc) WJS determ ined in chcmotaxill prcin cub:Hcd PMN L after subseq uent sti m ula tion w ith different chcmotaxins. Results arc expressed in 
percent of contro l. Note cross-deacti vation by MOC and ANAP. Resul ts of2 triplicate experi ments arc shown. 
·Xey: PMN L = polymorpho nuclea r leukocy te 
CSa = com ple ment spli t produ ct 
FMLP = for m yla ted tripeptide 
PA F = platelet-acti vating f.,ctor 
AN A P = anio nic neutrophil-acti vat ing pep ti de 
MOC = monocy te-derived chemotactic fac tor 
ity we were unable to identify any acti vity present at the elution 
position of C5a (Fig 4). Since a ncarl y 1 DO-fold lower dose of 
C 5a compared w ith C 5adcs "S is still suffi cient to elicit chemotactic 
ac ti vity in PMNL [21], it appears unlikel y that psoriatic sca les 
contain any signi fica nt amounts of the anaphylatoxin C5a. 
After generation of C5a by C5 convertase this anaphylatoxin 
is desarginated by ca rboxypeptidase N as thc principal anaphy-
latoxin inactivator [22]. Loss of arginine reduces the anaphylactic 
activity of C 5a nea rl y 1000-fold and this is kn own to take placc 
w ithin approximately 2 min in vivo [23]. In psorias is any newly 
generated C5 fragments may take at leas t several hours or days 
to be present within scale produ cts. T herefore it appears no t to 
be surprising to detect desarginated C5a only. 
Although C 5adcs "S is considerably weaker in PMNL stimu-
lating acti vity as compared with C 5a, the large quantities now 
detected in psoriatic scales ma y still be of im portance in the patho-
genesis of psorias is. In addition , C5adcs ors w as no t detectable in 
normal stratum corneum nor in scales from other scaling disorders 
including ichthyosiform eryth roderma (Schroder, unpublished 
data). T his suggests that complement activa tion plays a role in 
the pso riatic tissue reaction. 
This concept is indirectl y suppo rted by a recent stud y on neu-
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Figure 7. ,a-Glucuronidase liberating activity in fractions offG-75 cln o-
matography using control (opw circles) and neutrophils deactivated by 
MOe (so lid circles). Note the lowered response to fraction 43 which cor-
responds to the elution volume of the marker cytochrome c. 
trophil fun ctions in inflam matory skin diseases. U sing C5a as 
well as a va riety of o ther chemotaxins we were able to show that 
several patients w ith acti ve psoriasis showed a specific absence of 
PMNL res ponses to C5a [1 7]. At the same time PMNL functions 
elicited by FMLP, L TB4 , or PAF remained unaltered . 
T his was ta ken as evidence that in active psoriasis com plement 
activa tion with generation of C5 spl it produ cts is a significant 
fea ture. At prescnt it is not known cxactl y w here the generation 
of C 5 split produ cts takcs place, w hether in the dermis o r w ithin 
th e epidermis, nor do we know by w hat path way com plement 
becomes ac ti va ted . Still , the presence of compara tively large 
amounts of C5adcs a,s w ithin the horn y layer in pso ri asis is in-
triguing considering the va rious effects of this powerful cytotaxin 
in PMNL as well as in eosinophils, mast cells, basophils, or lym-
phocyte subsets [24]. 
The second scale chemo taxin identified here is an acidic com-
pourid w hich elutcs w ith a sli ghtly lower Mr as com pared w ith 
C 5adcs a,s (Fig 1). Anionic neutrophil-acti vating compounds in 
the range of 10-20 kD have no t been described before in psoriatic 
scales . T his could be due to technical reasons since characteriza ti on 
of chemotactic peptides from psoriatic sca les on the basis of charge 
are impeded by dras tic loss of yields in chemotactic activity [6]. 
For several reasons this AN AP appears to be di fferent from 
neutrophil-activa tin g peptides such as ETAF [25] or It- I [1 8] and 
leukocytic pyrogen [26]. 
Firs t, peak acti vity of ET AF derived from human epidermal 
cell culturcs was foun d between 15-30 kD [25] . Also as shown 
in a recent stud y, th e Mr of highl y purifi ed IJ- l was ncar 17,000 
[27]. These data di ffe r markedl y from the 12.5 k D seen fo r AN AP 
in our present study . 
Second , di ffe rences exist w ith regard to the isoelectric point 
(IP). Fo r human ET AF 3 IPs have been described [25] and sim-
ilarly, fo r highl y purified II-I 3 IPs have been shown [27]. O n 
the o ther hand , human ET AF demonstratin g defll1 ed chemotactic 
activity has been foun d to show only 2 IPs [28]. In these studies 
ET AF as well as lJ-l differed no t onl y w ith rega rd to the number 
but also w ith rega rd to the position of their IP . In contras t the 
anioni c scale peptide (A N AP) detccted here showed onl y a single 
IP at pH 6.8. 
T he reasons fo r these discrepancies are not clca r at the moment. 
In fac t, these peptides ma y represent a heterogenous group of 
mediato rs which, as stated by Luger et al [28], may di ffer in their 
fin al stru ctu re but have a region in com l11on. T he anionic scalc 
peptide (A NA P) described in this study could thus belong to this 
fa mily of peptide cy tokines including the m onocyte-derived fac-
tor M Oe. 
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It is noteworthy that in addition to psoriatic sca les we were 
able to extract ANAP from normal stratum corneum (callus) as 
well as from scales in patients with ichthyosiform erythroderma 
(Schroder, unpublished data). At present the role of this peptide 
in epidermal biology is not known, and also studies of the release 
mechanislils of this neutrophil-activating cytokine are needed . 
Taken together, our study shows that psoriatic scales contain 
2 newly defin ed neutrophil-activating peptides with marked bi-
ologic activities. Their presence within the epidermis may be 
related to pathogenic pathways not yet fu ll y explored. 
We are gratefully indebted to Miss C. Gerbreclll alld Miss C. Mehrens for their 
excellen t tec/Illica l assistmlce alld Mrs. l. Bottjer for typillg the IIJaIlI IScript. 
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